Tsumura & Co.

TSE:4540 Voorraadrapport

Marktkapitalisatie: JP¥370.5b

Tsumura Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Tsumura has been growing earnings at an average annual rate of 5.4%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 4.6% per year. Tsumura's return on equity is 8.2%, and it has net margins of 15%.

Belangrijke informatie

5.4%

Groei van de winst

5.5%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie3.4%
Inkomstengroei4.6%
Rendement op eigen vermogen8.2%
Nettomarge15.0%
Volgende winstupdate07 Nov 2024

Recente prestatie-updates uit het verleden

Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations

Aug 12
Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations

Recent updates

Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price

Oct 17
Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price

Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00

Sep 26
Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00

Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable

Sep 24
Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable

Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00

Sep 04
Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00

Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00

Aug 21
Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00

Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations

Aug 12
Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations

Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's

Jul 25
Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's

Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00

Jul 11
Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00

We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt

Jun 24
We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt

News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts

Mar 28
News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts

Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00

Mar 15
Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00

Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%

Mar 07
Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%

Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00

Feb 26
Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00

Opbrengsten en kosten

Hoe Tsumura geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSE:4540 Opbrengsten, kosten en inkomsten (JPY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24157,49923,55549,0470
31 Mar 24150,84516,70740,5118,288
31 Dec 23148,79316,75840,8507,594
30 Sep 23145,23813,59840,8527,594
30 Jun 23142,66214,18240,1797,594
31 Mar 23140,04316,48239,7717,594
31 Dec 22138,24019,32240,0577,313
30 Sep 22136,23720,76038,8967,313
30 Jun 22132,19220,07938,0557,313
31 Mar 22129,54618,83636,7757,313
31 Dec 21129,78317,36539,8796,631
30 Sep 21130,30517,21443,6566,631
30 Jun 21130,88616,67646,5676,631
31 Mar 21130,88315,33248,9176,631
31 Dec 20127,54515,43148,0636,270
30 Sep 20126,44014,81147,4936,270
30 Jun 20124,31713,90746,9806,270
31 Mar 20123,24813,76547,3536,270
31 Dec 19124,08114,55247,5655,926
30 Sep 19123,44014,54847,3595,926
30 Jun 19121,82914,98047,2585,926
31 Mar 19120,90614,59347,0095,926
31 Dec 18118,97813,93346,4826,048
30 Sep 18117,86514,97246,0656,048
30 Jun 18118,58714,82645,7126,048
31 Mar 18117,87914,50445,1766,048
31 Dec 17117,90613,62744,8996,087
30 Sep 17116,87713,79144,0886,087
30 Jun 17115,33012,73043,7586,087
31 Mar 17114,95412,48843,4296,087
31 Dec 16114,02213,07942,4565,968
30 Sep 16114,42411,33042,3295,968
30 Jun 16114,55712,37342,0385,968
31 Mar 16112,62512,55741,7755,968
31 Dec 15111,98612,55042,2676,252
30 Sep 15112,28814,48542,4406,252
30 Jun 15110,57014,20642,6946,252
31 Mar 15110,43814,07542,8356,252
31 Dec 14112,44515,40742,5365,949
30 Sep 14109,36917,10942,4995,949
30 Jun 14110,18717,24842,6165,949
31 Mar 14110,05718,05042,8595,949
31 Dec 13107,82118,02343,7564,904

Kwaliteitswinsten: 4540 has high quality earnings.

Groeiende winstmarge: 4540's current net profit margins (15%) are higher than last year (9.9%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 4540's earnings have grown by 5.4% per year over the past 5 years.

Versnelling van de groei: 4540's earnings growth over the past year (66.1%) exceeds its 5-year average (5.4% per year).

Winst versus industrie: 4540 earnings growth over the past year (66.1%) exceeded the Pharmaceuticals industry 38.7%.

Rendement op eigen vermogen

Hoge ROE: 4540's Return on Equity (8.2%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y